OneThree Biotech
About
What does OneThree Biotech do?
OneThree Biotech is a biology-driven artificial intelligence company that accelerates drug discovery and development. Their platform integrates diverse data types to identify novel targets, optimize compounds for toxicity and efficacy, and discover new therapeutic combinations. They aim to provide deeper mechanistic insights into drug action, improving the accuracy and success rate of preclinical R&D.
What is OneThree Biotech's revenue?
StartupHub estimates OneThree Biotech's annual revenue at $417K (range $164K to $1.2M, 28% confidence), based on comparable companies in the sector.
What is OneThree Biotech's valuation?
StartupHub estimates OneThree Biotech's effective valuation at $10.9M (range $7.0M to $16.8M, 10% confidence), based on comparable companies in the sector.
How much funding has OneThree Biotech raised?
OneThree Biotech has raised a total of $3M in funding. The most recent round on record is Seed.
Where is OneThree Biotech headquartered?
OneThree Biotech is headquartered in New York City, United States.
When was OneThree Biotech founded?
OneThree Biotech was founded in 2018.
What industry does OneThree Biotech operate in?
OneThree Biotech operates in Biotech, HealthTech, Drug Discovery, AI-Driven Protein Design, Genomics, Clinical Trials.
No comments yet. Be the first to share your take.